CG Oncology, Inc. (CGON) Free cash flow 2024–2025
CG Oncology, Inc. (CGON) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$132.5MFY2025 · since FY2024: -$78.9M → -$132.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$132.5M | -67.8% |
| FY2024 | -$78.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CGON financial trends
CGON RevenueCGON Net incomeCGON Net marginCGON Gross profitCGON Gross marginCGON Operating incomeCGON Operating marginCGON Operating cash flowCGON Capital expendituresCGON Return on equityCGON Stock buybacksCGON Dividends paidCGON Total assetsCGON Total liabilitiesCGON Shareholders’ equityCGON overview →